Beam Therapeutics Inc (BEAM) insider trading
Every open-market stock purchase and sale by Beam Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $17.6M over the last 12 months (19 sales). No open-market buys.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $17.6M (19 sales). Last close $29.40 on Jun 4, 2026.
Recent BEAM insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 6, 2033 | Kathleen E Walsh (Insider) | Bought (not open market) | — |
| Jun 26, 2026 | Fmr LLC (Insider) | Sold | $8.9M |
| Jun 25, 2026 | Fmr LLC (Insider) | Sold | $1.2M |
| Jun 17, 2026 | Giuseppe Ciaramella (President) | Bought (not open market) | — |
| Jun 17, 2026 | Giuseppe Ciaramella (President) | Bought (not open market) | — |
| Jun 3, 2026 | Graham K Cooper (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | John Maraganore (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Mark Fishman (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Chirfi Guindo (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Christi Shaw (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Kathleen E Walsh (Insider) | Bought (not open market) | — |
| Apr 1, 2026 | John M. Evans (CEO) | Sold | $739K |
| Apr 1, 2026 | Giuseppe Ciaramella (President) | Sold | $290K |
| Apr 1, 2026 | Amy Simon (C-suite exec) | Sold | $165K |
| Apr 1, 2026 | Christine Bellon (C-suite exec) | Sold | $146K |
| Apr 1, 2026 | Bethany J Cavanagh (VP) | Sold | $79.7K |
| Mar 31, 2026 | John M. Evans (CEO) | Sold | $569K |
| Mar 31, 2026 | John M. Evans (CEO) | Bought (not open market) | — |
| Mar 31, 2026 | Christine Bellon (C-suite exec) | Bought (not open market) | — |
| Mar 31, 2026 | John M. Evans (CEO) | Bought (not open market) | — |
| Mar 31, 2026 | Bethany J Cavanagh (VP) | Bought (not open market) | — |
| Mar 31, 2026 | Amy Simon (C-suite exec) | Bought (not open market) | — |
| Mar 31, 2026 | Sravan Kumar Emany (CFO) | Bought (not open market) | — |
| Mar 31, 2026 | Giuseppe Ciaramella (President) | Bought (not open market) | — |
| Mar 30, 2026 | John M. Evans (CEO) | Sold | $559K |
Who's trading BEAM
- Kathleen E Walsh, Insider: other filings, last Jun 6, 2033
- Fmr LLC, Insider: sold $10.1M (3 sales), last Jun 26, 2026
- Giuseppe Ciaramella, President: sold $1.4M (2 sales), last Jun 17, 2026
- Graham K Cooper, Insider: other filings, last Jun 3, 2026
- Mark Fishman, Insider: other filings, last Jun 3, 2026
- Chirfi Guindo, Insider: other filings, last Jun 3, 2026
- John Maraganore, Insider: other filings, last Jun 3, 2026
- Christi Shaw, Insider: other filings, last Jun 3, 2026
- Bethany J Cavanagh, VP: sold $399K (4 sales), last Apr 1, 2026
- Amy Simon, C-suite exec: sold $165K (1 sale), last Apr 1, 2026
- John M. Evans, CEO: sold $4.5M (9 sales), last Apr 1, 2026
- Christine Bellon, C-suite exec: sold $881K (7 sales), last Apr 1, 2026
- Sravan Kumar Emany, CFO: sold $171K (1 sale), last Mar 31, 2026
Get free alerts when an insider at Beam Therapeutics Inc files a new trade →